Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the Treatment of Metabolic Diseases and Nonalcoholic Steatohepatitis (NASH)
Por um escritor misterioso
Descrição
Targeting diacylglycerol acyltransferase 2 for the treatment of
Novel antisense inhibition of diacylglycerol O-acyltransferase 2
Monoacylglycerol Acyltransferase 2 (MGAT2) Inhibitors for the
Pharmacotherapies of NAFLD: updated opportunities based on
Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2
PDF) Discovery and Optimization of Imidazopyridine-based
US9701672B2 - Dihydropyridinone MGAT2 inhibitors for use in the
NASH Drug Development: Seeing the Light at the End of the Tunnel?
US9701672B2 - Dihydropyridinone MGAT2 inhibitors for use in the
de
por adulto (o preço varia de acordo com o tamanho do grupo)
